about
Telocyte dynamics in psoriasis.Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance.CYR61/CCN1: A Novel Mediator of Epidermal Hyperplasia and Inflammation in Psoriasis?Deranged iron status in psoriasis: the impact of low body mass.Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis CSystemic abnormalities of psoriatic patients: a retrospective study.Prokineticin 2 Plays a Pivotal Role in Psoriasis.A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast.Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.Psoriasis, Depression, and Inflammatory Overlap: A Review.Review of phase III trial data on IL-23 inhibitors tildrakizumab and guselkumab for psoriasis.Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.Ultraviolet B Inhibits IL-17A/TNF-α-Stimulated Activation of Human Dermal Fibroblasts by Decreasing the Expression of IL-17RA and IL-17RC on FibroblastsCalcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based reviewIL-22-induced miR-122-5p promotes keratinocyte proliferation by targeting Sprouty2.A Correlative Study between Platelet Count, Mean Platelet Volume and Red Cell Distribution Width with the Disease Severity Index in Psoriasis Patients.Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.Effect of Calcipotriol on IFN-γ-Induced Keratin 17 Expression in Immortalized Human Epidermal Keratinocyte Cells.Expression of inflammatory cytokines in psoriatic nails.Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis.Effects of Wannachawee Recipe with Antipsoriatic Activity on Suppressing Inflammatory Cytokine Production in HaCaT Human Keratinocytes.T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum.Psoriasis: A STAT3-Centric View.Skin Microbiome: An Actor in the Pathogenesis of Psoriasis.Human Langerhans Cells with Pro-inflammatory Features Relocate within Psoriasis Lesions.Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells.Elevated Gene Expression of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Peripheral Blood of Chronic Psoriatic Patients.Topical heat shock protein 70 prevents imiquimod-induced psoriasis-like inflammation in mice.Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis.Update on the treatment of psoriasis and psoriatic arthritis - role of apremilast.Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort.Psoriasis & cardiovascular morbidity: The missing links?RNA sequencing-based longitudinal transcriptomic profiling gives novel insights into the disease mechanism of generalized pustular psoriasis.Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of PsoriasisPsoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
P2860
Q35879487-1F05CC6A-7651-4B06-8D11-D03DDCB5B7FBQ35922976-9392542F-A309-4976-8C5C-ED2A52545822Q36269358-54834AD0-4B75-4651-AB75-0EB59061BBF2Q36349371-17EA57E3-2EEA-4DB3-96E1-8162C2D7AEEEQ36522235-88D9A3AE-FA9B-4192-80CC-99F06ED000FDQ37412932-90C91C87-7E57-4C51-B673-8AA3E9F9F59DQ37604630-A8C16048-D1C5-4893-8139-5A9EE8F51313Q38675867-A0E243A6-4C5A-4CAF-8973-B1828554219DQ38684354-F3E5184E-3542-44E5-83D0-0E1221751FEAQ38692102-D8A21825-2FD8-4C5C-922A-577EAA0C54F2Q38698960-1FBB8FFC-26C6-46D2-BCFE-BCD7D62276F0Q39493410-689F5ACB-D72F-4C6D-BD58-3D904651A9A4Q39947458-1F68FADD-343C-41E6-86F3-2CC960382DC6Q41035494-3FABC6E6-25F8-49D2-9ECC-92B53AA0A7C9Q42324322-E790CEF5-01EA-4481-BB1A-433AD5DCC06BQ42370586-1F1B874C-2BFB-48BB-A023-6EB49C8F5D3DQ42502966-23968F8F-C1BF-4D7C-96EB-5DB133DEC703Q47097230-7B5D1038-30AB-4275-B94B-7FB86803F33DQ47098090-B2DB6649-2191-40E1-8289-7869B4D4CC29Q47142102-3E61AFA0-B48F-4081-B4CE-803D84EDCC78Q47274718-C3E54626-D858-4720-B577-7199F7F54796Q47640799-F67C901A-1DEE-4398-B000-BBD49C4681C4Q47813610-F15779CE-4E68-4875-A105-5A1247F9046DQ48127326-1AEDF801-293D-4B27-89C7-CAA16847C7D1Q48278607-5AFA8655-9F3D-46FD-98D0-1870073D5C66Q49288597-2E0B751D-9F15-43C4-9213-73AF6C07C293Q50531635-105B7F3C-C42D-4996-A227-E99ACAF03D01Q51690338-7B616E17-6F9B-4B1D-901E-2E33CA5CF9CDQ52656050-96639267-1118-48B3-9852-D593D355078DQ52721777-DF6E6F85-19A5-48DD-8D37-F044FA92A363Q55163181-8EC9E5FC-2DF8-4E73-81D5-8A7146DA5B9AQ55177045-1D07B493-12E9-4569-82B5-DC6B5F7BDE54Q55217066-47096B1B-E8FD-4AA1-930C-0E43CFD6A200Q55365402-F0D86656-8BAB-41D6-AFB0-8C266F466AF5Q55378699-006EFE73-F39F-49FE-A888-269C958EB159Q58290837-EABD1987-F9CE-48CF-A147-791374537448Q58785751-CDF7BF1C-A307-4D11-B44C-8EE931308117
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cytokines in psoriasis
@ast
Cytokines in psoriasis
@en
Cytokines in psoriasis
@nl
type
label
Cytokines in psoriasis
@ast
Cytokines in psoriasis
@en
Cytokines in psoriasis
@nl
prefLabel
Cytokines in psoriasis
@ast
Cytokines in psoriasis
@en
Cytokines in psoriasis
@nl
P2860
P3181
P1433
P1476
Cytokines in psoriasis
@en
P2093
Drew H Barnes
Jaymie Baliwag
P2860
P304
P3181
P356
10.1016/J.CYTO.2014.12.014
P407
P50
P577
2015-01-10T00:00:00Z